share_log

金凯生科(301509.SZ):在口服多肽项目方面,公司专注于SNAC中间体的工艺开发与生产服务

Jinkai Biosciences (301509.SZ): In the field of oral polypeptide projects, the company focuses on the process development and production services of SNAC intermediates.

Gelonghui Finance ·  Aug 2 04:22

On August 2nd, Gelunhui reported that Jinkai Life Sciences (301509.SZ) stated on its investor interaction platform that the company's existing fluorination production capacity includes special fluorination agents (such as sulfur tetrafluoride, pyridine hydrofluoride, hydrogen fluoride triethylamine), hydrogen fluoride fluorination, potassium fluoride fluorination, electrolytic fluorination, etc.; in terms of oral peptide projects, the company focuses on the process development and production services of SNAC intermediates.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment